Le poids économique hospitalier de la goutte, pseudogoutte et autres arthropathies microcristallines en France

Garg, 2013, Gout-related health care utilization in US emergency departments, 2006 through 2008, Arthritis Care Res (Hoboken), 65, 571, 10.1002/acr.21837

Robinson, 2013, Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999–2009, Rheumatology (Oxford), 52, 118, 10.1093/rheumatology/kes253

Zhu, 2011, Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008, Arthritis Rheum, 63, 3136, 10.1002/art.30520

Winnard, 2012, National prevalence of gout derived from administrative health data in Aotearoa, New Zealand, Rheumatology (Oxford), 51, 901, 10.1093/rheumatology/ker361

Annemans, 2008, Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005, Ann Rheum Dis, 67, 960, 10.1136/ard.2007.076232

Singh, 2008, Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans, Ann Rheum Dis, 67, 1310, 10.1136/ard.2007.081604

Wu, 2011, Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy, Am J Ther, 19, e157, 10.1097/MJT.0b013e31820543c5

Perez-Ruiz, 2013, Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout, Ann Rheum Dis, 10.1136/annrheumdis-2012-eular.1785

Park, 2012, Evaluation of health care costs and utilization patterns for patients with gout, Clin Ther, 34, 640, 10.1016/j.clinthera.2012.01.020

Wu, 2008, Disease-related and all-cause health care costs of elderly patients with gout, J Manag Care Pharm, 14, 164, 10.18553/jmcp.2008.14.2.164

Halpern, 2009, The effect of serum urate on gout flares and their associated costs: an administrative claims analysis, J Clin Rheumatol, 15, 3, 10.1097/RHU.0b013e3181945d2c

Hanly, 2009, Gout in the elderly: a population health study, J Rheumatol, 36, 822, 10.3899/jrheum.080768

Lee, 2012, Healthcare burden of in-hospital gout, Intern Med J, 42, 1261, 10.1111/j.1445-5994.2012.02747.x

Wertheimer, 2013, A revised estimate of the burden of illness of gout, Curr Ther Res Clin Exp, 75, 1, 10.1016/j.curtheres.2013.04.003

Nitichaikulvatana, 2011, Impact of deficits in gout care on hospitalizations, J Clin Rheumatol, 17, 389, 10.1097/RHU.0b013e318232615b

Reach, 2011, Treatment adherence in patients with gout, Joint Bone Spine, 78, 456, 10.1016/j.jbspin.2011.05.010

Rees, 2013, Patients with gout adhere to curative treatment if informed appropriately: proof of concept observational study, Ann Rheum Dis, 72, 826, 10.1136/annrheumdis-2012-201676

Liote, 2012, GOSPEL: prospective survey of gout in France. Part I: design and patient characteristics (n=1003), Joint Bone Spine, 79, 464, 10.1016/j.jbspin.2011.12.006